Definium Therapeutics (DFTX) EPS (Basic) (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.00% |
| Dec 31, 2025 | 35.90% |
| Sep 30, 2025 | -56.00% |
| Jun 30, 2025 | -85.19% |
| Mar 31, 2025 | 35.71% |
| Dec 31, 2024 | -133.33% |
| Sep 30, 2024 | -125.00% |
| Jun 30, 2024 | 92.98% |
| Mar 31, 2024 | -93.22% |
| Dec 31, 2023 | -31.11% |
| Sep 30, 2023 | 40.79% |
| Jun 30, 2023 | -16.92% |
| Mar 31, 2023 | -3,150.00% |
| Dec 31, 2022 | 96.43% |
| Sep 30, 2022 | 6.67% |
| Jun 30, 2022 | 9.09% |
| Mar 31, 2022 | -11.86% |
| Dec 31, 2021 | 3.28% |
| Sep 30, 2021 | -454.55% |
| Jun 30, 2021 | -175.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -233.33% |
| Sep 30, 2020 | 50.00% |
| Jun 30, 2020 | 166.67% |
| Mar 31, 2020 | 70.00% |